Treatment patterns, health care resource use and outcomes in metastatic triple-negative breast cancer in Germany: retrospective chart review study (OBTAIN)

2019 ◽  
Vol 35 (8) ◽  
pp. 1405-1414 ◽  
Author(s):  
Jörg Schilling ◽  
Steffi Busch ◽  
Georg Heinrich ◽  
Karin Heinig ◽  
Christian Martin Kurbacher ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Health Care ◽  
Triple Negative Breast Cancer ◽  
Resource Use ◽  
Chart Review ◽  
Triple Negative ◽  
Retrospective Chart Review ◽  
Treatment Patterns ◽  
Health Care Resource ◽  
Review Study

scholarly journals Retrospective Chart Review Study to Evaluate Health Care Resource Utilization in Patients with Symptomatic Multiple Myeloma in Italy

2016 ◽  
Vol 19 (3) ◽  
pp. A155-A156 ◽  
Author(s):  
S Gonzalez-McQuire ◽  
K Yong ◽  
A Flinois ◽  
C Gazzola ◽  
P Schoen ◽  
...  
Keyword(s):  
Health Care ◽  
Multiple Myeloma ◽  
Resource Utilization ◽  
Chart Review ◽  
Retrospective Chart Review ◽  
Health Care Resource ◽  
Health Care Resource Utilization ◽  
Review Study

scholarly journals Treatment Patterns and Clinical Outcomes in Advanced Lung Neuroendocrine Tumors in Real‐World Settings: A Multicenter Retrospective Chart Review Study

2019 ◽  
Vol 24 (8) ◽  
pp. 1066-1075
Author(s):  
Arvind Dasari ◽  
Emily K. Bergsland ◽  
Al B. Benson ◽  
Beilei Cai ◽  
Lynn Huynh ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Neuroendocrine Tumors ◽  
Real World ◽  
Chart Review ◽  
Retrospective Chart Review ◽  
Treatment Patterns ◽  
Review Study

Treatment Patterns Among Women Diagnosed With Stage I-III Triple-negative Breast Cancer

2018 ◽  
Vol 41 (10) ◽  
pp. 997-1007 ◽  
Author(s):  
Helmneh M. Sineshaw ◽  
Rachel A. Freedman ◽  
Carol E. DeSantis ◽  
Ahmedin Jemal
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Treatment Patterns ◽  
Stage I

Early triple-negative breast cancer in women aged ≥65: retrospective study of outcomes, resource use and costs, 2010–2016

2020 ◽  
Author(s):  
Jan Sieluk ◽  
Amin Haiderali ◽  
Min Huang ◽  
Lingfeng Yang ◽  
Kim M Hirshfield
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Resource Use ◽  
Median Overall Survival ◽  
Triple Negative ◽  
Healthcare Resource ◽  
Early Stage ◽  
Stage Ii ◽  
Medicare Database ◽  
Therapy Treatment

Aim: To examine real-world treatment patterns and outcomes in neoadjuvant and adjuvant settings for early-stage triple-negative breast cancer (TNBC). Patients & methods: Using the SEER-Medicare database, we identified patients (≥65 years) with newly diagnosed stage II/III TNBC in 2010–2015 who had surgery plus neoadjuvant and/or adjuvant (systemic and/or radiation) therapy. Treatment, survival, healthcare resource use and costs were assessed through 2016. Results: Of 1569 patients (>99% women), 6%/74%/20% received neoadjuvant-only/adjuvant-only/both (neo + adj) therapies, respectively. Median overall survival was 23 months/not reached (NR)/78 months, with longer survival at stage II (NR/NR/78 months) than stage III (22/43/38 months). Mean per-patient-per-month costs were $10,620 and $17,872 in neoadjuvant and adjuvant periods. Conclusion: These findings provide insights into clinical and economic outcomes for early-stage TNBC in 2010–2016.

scholarly journals A population‐based comparison of treatment patterns, resource utilization, and costs by cancer stage for Ontario patients with triple‐negative breast cancer

2020 ◽  
Vol 9 (20) ◽  
pp. 7548-7557
Author(s):  
Christine Brezden‐Masley ◽  
Kelly E. Fathers ◽  
Megan E. Coombes ◽  
Behin Pourmirza ◽  
Cloris Xue ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Resource Utilization ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Population Based ◽  
Treatment Patterns ◽  
Cancer Stage
Sign in / Sign up

Export Citation Format

Share Document